471 related articles for article (PubMed ID: 26634783)
21. Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease.
Vonghia L; Van Herck MA; Weyler J; Francque S
Front Immunol; 2019; 10():563. PubMed ID: 30972062
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte and immune cell crosstalk in non-alcoholic fatty liver disease.
Carranza-Trejo AM; Vetvicka V; Vistejnova L; Kralickova M; Montufar EB
Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):783-796. PubMed ID: 33557653
[No Abstract] [Full Text] [Related]
23. Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease.
Luci C; Vieira E; Perchet T; Gual P; Golub R
Front Immunol; 2019; 10():1192. PubMed ID: 31191550
[TBL] [Abstract][Full Text] [Related]
24. Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.
Joshi-Barve S; Kirpich I; Cave MC; Marsano LS; McClain CJ
Cell Mol Gastroenterol Hepatol; 2015 Jul; 1(4):356-367. PubMed ID: 28210688
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?
Handa P; Vemulakonda A; Kowdley KV; Uribe M; Méndez-Sánchez N
World J Gastroenterol; 2016 Aug; 22(31):6965-71. PubMed ID: 27610009
[TBL] [Abstract][Full Text] [Related]
26. Increased ratio of neutrophil elastase to α1-antitrypsin is closely associated with liver inflammation in patients with nonalcoholic steatohepatitis.
Zang S; Ma X; Zhuang Z; Liu J; Bian D; Xun Y; Zhang Q; Zhao F; Yang W; Liu J; Luo Y; Liu Y; Ye B; Ye D; Shi J
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):13-21. PubMed ID: 26444279
[TBL] [Abstract][Full Text] [Related]
27. NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice.
Tosello-Trampont AC; Krueger P; Narayanan S; Landes SG; Leitinger N; Hahn YS
Hepatology; 2016 Mar; 63(3):799-812. PubMed ID: 26662852
[TBL] [Abstract][Full Text] [Related]
28. Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis.
Li H; Zhou Y; Wang H; Zhang M; Qiu P; Zhang M; Zhang R; Zhao Q; Liu J
Front Immunol; 2020; 11():1169. PubMed ID: 32670278
[TBL] [Abstract][Full Text] [Related]
29. Immunology in alcoholic liver disease.
Duddempudi AT
Clin Liver Dis; 2012 Nov; 16(4):687-98. PubMed ID: 23101977
[TBL] [Abstract][Full Text] [Related]
30. Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?
Gao B; Tsukamoto H
Gastroenterology; 2016 Jun; 150(8):1704-9. PubMed ID: 26826669
[No Abstract] [Full Text] [Related]
31. Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis.
Handa P; Vemulakonda AL; Maliken BD; Morgan-Stevenson V; Nelson JE; Dhillon BK; Hennessey KA; Gupta R; Yeh MM; Kowdley KV
Ann Hepatol; 2017 Jan-Feb 2017; 16(1):77-85. PubMed ID: 28051796
[TBL] [Abstract][Full Text] [Related]
32. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
[TBL] [Abstract][Full Text] [Related]
33. The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis.
Cai J; Zhang XJ; Li H
Hepatology; 2019 Sep; 70(3):1026-1037. PubMed ID: 30653691
[TBL] [Abstract][Full Text] [Related]
34. The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise.
Wu L; Gao X; Guo Q; Li J; Yao J; Yan K; Xu Y; Jiang X; Ye D; Guo J
Hepatol Int; 2020 Sep; 14(5):652-666. PubMed ID: 32880077
[TBL] [Abstract][Full Text] [Related]
35. Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies.
Luci C; Bourinet M; Leclère PS; Anty R; Gual P
Front Endocrinol (Lausanne); 2020; 11():597648. PubMed ID: 33384662
[TBL] [Abstract][Full Text] [Related]
36. Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism.
Jegatheesan P; De Bandt JP
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28273805
[TBL] [Abstract][Full Text] [Related]
37. Innate immunity in alcoholic liver disease.
Gao B; Seki E; Brenner DA; Friedman S; Cohen JI; Nagy L; Szabo G; Zakhari S
Am J Physiol Gastrointest Liver Physiol; 2011 Apr; 300(4):G516-25. PubMed ID: 21252049
[TBL] [Abstract][Full Text] [Related]
38. Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice.
Handa P; Morgan-Stevenson V; Maliken BD; Nelson JE; Washington S; Westerman M; Yeh MM; Kowdley KV
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G117-27. PubMed ID: 26564716
[TBL] [Abstract][Full Text] [Related]
39. Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis.
Houben T; Brandsma E; Walenbergh SMA; Hofker MH; Shiri-Sverdlov R
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Apr; 1862(4):416-429. PubMed ID: 27472963
[TBL] [Abstract][Full Text] [Related]
40. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
